In contrast, a meta-analysis conducted by Zhang et al. reported significantly shorter OS rates and advanced tumor stages in patients with positive TIM-3 expression in various solid tumors including colon cancer, gastric cancer, renal cell carcinoma and non-small cell lung cancer (NSCLC) [28]. The gene discussed is HAVCR2; the disease is gastric cancer.